Regulatory Filing Details

Key Findings

The company confirmed that there are no deviation(s) or variation(s) during the quarter ended 30th June, 2026 in respect of utilization of proceeds raised through both the Preferential Issue and Rights Issue.

Fund Raising Details

Preferential Issue (October 25, 2024)

  • Instrument: 2,92,000 Equity Shares and 19,20,000 Equity Convertible Warrants of Face Value of ₹10 each
  • Amount Raised: ₹14.16 Crores
  • Monitoring Agency: Not Applicable

Rights Issue (March 24, 2026)

  • Instrument: 29,38,500 fully paid-up equity shares of face value of ₹10 each
  • Issue Price: ₹75 per share including share premium of ₹65 per share
  • Amount Raised: ₹22.03875 Crores (Gross Proceeds)
  • Ratio: 1 rights equity share for every 2 fully paid-up equity shares held
  • Monitoring Agency: CARE Ratings Limited

Fund Utilization Status

Preferential Issue Utilization (As of June 30, 2026)

  • Investment in Shares & Securities: ₹13.888 Crores (100% utilized)
  • Working Capital Requirements: ₹0.2688 Crores (100% utilized)
  • No funds remain unutilized

Rights Issue Utilization (As of June 30, 2026)

  • Investment in Shares and securities and Mutual funds schemes: ₹13.55 Crores (100% utilized)
  • Investment in Liquid Funds Schemes: ₹2.78 Crores (100% utilized)
  • General corporate purposes (GCP): ₹5.40 Crores (100% utilized)
  • Estimated Issue related expenses: ₹0.26 Crores utilized out of ₹0.30 Crores allocated
  • Unutilized Balance: ₹0.04 Crores for issue-related expenses

The unutilized balance of ₹0.04 Crores is currently held in the Company's monitoring account/fixed deposits as per the terms of the issue and has been earmarked for utilization in the September quarter of Financial Year 2026-27, as and when incurred.

Governance and Approval

The statement has been reviewed by the Audit Committee and taken on record by the Board at their respective meetings held on August 11, 2026. The audit committee commented that "Everything is in order" for both issues.

Additional Information

A copy of the statement is being uploaded on the company's website at www.nexomecap.com. The company's registered office is at "VAIBHAV" (4F), 4 Lee Road, Kolkata - 700 020.